Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2022 Earnings Ca

Operator: Greetings, and welcome to Fulcrum Therapeutics Fourth Quarter and Full Year 2022 Earnings Conference Call. As a reminder, this conference is being recorded.

Related Keywords

United States , Canada , Santiago , Regióetropolitana , Chile , America , Matt Biegler , Alan Ezekowitz , Acceleron Pharma , Robertj Gould , Iain Fraser , Madhu Kumar , Ted Tenthoff , Matthew Biegler , Edward Tenthoff , Piper Sandler , Robert Gould , Chris Calabrese , Matthew Harrison , Judah Frommer , Esther Rajavelu , Tazeen Ahmad , Joseph Schwartz , Morgan Stanley , Elevate Bio Company , Goldman Sachs , Credit Suisse , Nasdaq , Exchange Commission , Fulcrum Therapeutics Inc , Lundbeck , Fulcrum Therapeutics , Call Transcript March , Fulcrum Therapeutics Fourth Quarter , Full Year , Business Update Conference , Private Securities Litigation Reform Act , Interim Chief Executive Officer , Chief Financial Officer , Fulcrum Board , Muscle Fat Infiltration , Patient Global Impression , Santiago Arroyo , Chief Medical Officer , Vice President , Clinical Fellow , Elevate Bio , Abide Therapeutics , Dan Gon ,